Parameters | N | % |
---|---|---|
Age, mean (range) | 46 years (24–67 years) | |
Histology | ||
Small cell | 71 | 80.7 |
Pure | 48 | 54.5 |
Mixed with AdC | 17 | 19.3 |
Mixed with SqC or adenosquamous carcinoma | 6 | 6.8 |
Large cell | 8 | 9.1 |
Pure | 6 | 6.8 |
Mixed with small cell | 2 | 2.3 |
Neuroendocrine, NOS | 9 | 10.2 |
Pure | 6 | 6.8 |
Mixed with AdC | 3 | 3.4 |
FIGO stage (2018) | ||
I | 42 | 47.7 |
II | 9 | 10.2 |
III | 27 | 30.7 |
IVa | 2 | 2.3 |
N/A | 8 | 9.1 |
Tumor size | ||
≤ 4.0 cm | 41 | 46.6 |
> 4.0 cm | 19 | 21.6 |
N/A | 28 | 31.8 |
Depth of cervical stromal invasion | ||
< 1/3 | 22 | 25.0 |
≥ 1/3 | 57 | 64.8 |
N/A | 9 | 10.2 |
lymphovascular space invasion | ||
Yes | 55 | 62.5 |
No | 12 | 13.6 |
N/A | 21 | 23.9 |
Pelvic lymph node metastasis | ||
Yes | 29 | 33.0 |
No | 53 | 60.2 |
N/A | 6 | 6.8 |
Primary treatment | ||
Radiation | 53 | 60.2 |
Cycle of chemotherapy | ||
< 4 | 16 | 18.2 |
≥ 4 | 72 | 81.8 |